Michele Sartori is a Cardiology physician. OpenAlex indexes 32 publications with 968 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6624 Fannin St Ste 2750
Houston, TX 770302338
Telephone
713-797-1330Provider last certified this registry record 23 Mar 2026.
Industry payments
51 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202536 payments$62,633openpaymentsdata.cms.gov ↗
- Abbott LaboratoriesProgram year202519 payments
- ABIOMEDProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
84.4%Other lipid modifying agents50.7%Inclisiran100%Vascepa0%Part D + Part B<11 patientsStatin7%Atorvastatin Calcium56%Rosuvastatin Calcium38%Pravastatin Sodium4%Livalo2%Part D<11 patients+ 20 more classes in this area
Metabolism & gastrointestinal
4.8%Proton pump inhibitor1%Pantoprazole Sodium85%Omeprazole15%Part D<11 patientsSGLT2 inhibitor0.9%Jardiance66%Farxiga34%Part D≥22 patients+ 5 more classes in this area
Blood & clotting
4.5%Factor Xa inhibitor2.7%Eliquis77%Xarelto23%Part D≥70 patientsP2Y12 inhibitor1.1%Clopidogrel87%Prasugrel Hcl13%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1985–1986 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- BILATERAL CORONARY ARTERY FISTULAS: TRANSCATHETER EMBOLIZATION OR SURGICAL LIGATION?
Journal of the American College of Cardiology
2024 - Cosmos: 4 collections, 654 merveilles, 12 mondes, un palais: grande exposition
HAL (Le Centre pour la Communication Scientifique Directe)
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”